Evidence map›Paper›PMID 18086889›Full record

ArticleMolecular and cellular biology2008

The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.

Kevin W Trotter, Hua-Ying Fan, Melissa L Ivey, Robert E Kingston, Trevor K Archer

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. The role of SMARCA4 in lung cancer.Scientific reports · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targetsProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  10. Article
  11. Review
  12. The molecular basis of selective DNA binding by the BRG1 AT-hook and bromodomain.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Temporal regulation of chromatin during myoblast differentiation.Seminars in cell & developmental biology · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kevin W TrotterLaboratory of Molecular Carcinogenesis, NIEHS/NIH, Research Triangle Park, NC 27709, USA.
Hua-Ying Fan
Melissa L Ivey
Robert E Kingston
Trevor K Archer
National Institute of Environmental Health Sciences · USFox Chase Cancer Center · USHarvard University · USResearch Triangle Park Foundation · US

Funding

Transcriptional Functions of Nuclear Receptors in Cancer CellsZ01ES071006 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ARCHER, TREVOR KEITH · 1999 to 2008
$6.9M
Functional Analysis of SWI/SNF chromatin remodelersK01CA093660 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI FAN, HUA-YING · 2003 to 2007
$611k
Intramural NIH HHSNCI NIH HHS CA-093660NCI NIH HHS K01 CA093660
6 · The paper itself

Abstract

The packaging of eukaryotic DNA into chromatin can create an impediment to transcription by hindering binding of essential factors required for transcription. The mammalian SWI/SNF remodeling complex has been shown to alter local chromatin structure and facilitate recruitment of transcription factors. BRG1 (or hBrm), the central ATPase of the human SWI/SNF complex, is a critical factor for the functional activity of nuclear receptor complexes. Analysis using BRG1/SNF2h chimeras suggests BRG1 may contain previously uncharacterized functional motifs important for SWI/SNF. To identify these regions, BRG1 truncation and deletion mutants were designed, characterized, and utilized in a series of assays to evaluate transcriptional activation and chromatin remodeling by the glucocorticoid receptor. We identified a domain within the N terminus of BRG1 that mediates critical protein interactions within SWI/SNF. We find the HSA domain of BRG1 is required to mediate the interaction with BAF250a/ARID1A and show this association is necessary for transcriptional activation from chromatin mouse mammary tumor virus or endogenous promoters in vivo. These studies suggest BAF250a is a necessary facilitator of BRG1-mediated chromatin remodeling required for SWI/SNF-dependent transcriptional activation.

Indexed as

Transcriptional ActivationAnimalsChromatin Assembly and DisassemblyChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA HelicasesHumansMammary Tumor Virus, MouseMiceMutant ProteinsNuclear ProteinsPromoter Regions, GeneticProtein BindingProtein Structure, TertiaryProtein SubunitsReceptors, GlucocorticoidARID1A protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA HelicasesMutant ProteinsNuclear ProteinsProtein SubunitsReceptors, GlucocorticoidSMARCA4 protein, humanSWI-SNF-B chromatin-remodeling complexTranscription Factors

Identifiers

PMID18086889
PMCPMC2258747
OpenAlexW2116101416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.